Trial Profile

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Edaravone (Primary)
Indications Amyotrophic lateral sclerosis; Cerebral infarction; Stroke
Focus Pharmacokinetics
Sponsors Mitsubishi Tanabe Pharma Corporation

Most Recent Events

11 Nov 2022 Results(from 3 Phase I clinical studies NCT04481750 n=6, NCT04481789 n=9, and NCT05342597 n=16) assessing the effect of food on the pharmacokinetic profiles of a single dose of edaravone oral suspension in Healthy Participants published in the Clinical Therapeutics
28 Apr 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com